Assessment of the capacity to consent to treatment in patients admitted to acute medical wards. by Fassassi, S. et al.
BioMed CentralBMC Medical Ethics
ssOpen AcceResearch article
Assessment of the capacity to consent to treatment in patients 
admitted to acute medical wards
Sylfa Fassassi*†1, Yanik Bianchi†2, Friedrich Stiefel1 and Gérard Waeber2
Address: 1Service of Liaison Psychiatry, CHUV-University hospital, Lausanne, Switzerland and 2Department of Internal Medicine, CHUV-
University hospital, Lausanne, Switzerland
Email: Sylfa Fassassi* - Sylfa.Fassassi@chuv.ch; Yanik Bianchi - yanikbianchi@yahoo.fr; Friedrich Stiefel - Frederic.Stiefel@chuv.ch; 
Gérard Waeber - Gerard.Waeber@chuv.ch
* Corresponding author    †Equal contributors
Abstract
Background: Assessment of capacity to consent to treatment is an important legal and ethical
issue in daily medical practice. In this study we carefully evaluated the capacity to consent to
treatment in patients admitted to an acute medical ward using an assessment by members of the
medical team, the specific Silberfeld's score, the MMSE and an assessment by a senior psychiatrist.
Methods: Over a 3 month period, 195 consecutive patients of an internal medicine ward in a
university hospital were included and their capacity to consent was evaluated within 72 hours of
admission.
Results: Among the 195 patients, 38 were incapable of consenting to treatment (unconscious
patients or severe cognitive impairment) and 14 were considered as incapable of consenting by the
psychiatrist (prevalence of incapacity to consent of 26.7%). Agreement between the psychiatrist's
evaluation and the Silberfeld questionnaire was poor (sensitivity 35.7%, specificity 91.6%).
Experienced clinicians showed a higher agreement (sensitivity 57.1%, specificity 96.5%). A decision
shared by residents, chief residents and nurses was the best predictor for agreement with the
psychiatric assessment (sensitivity 78.6%, specificity 94.3%).
Conclusion: Prevalence of incapacity to consent to treatment in patients admitted to an acute
internal medicine ward is high. While the standardized Silberfeld questionnaire and the MMSE are
not appropriate for the evaluation of the capacity to consent in this setting, an assessment by the
multidisciplinary medical team concurs with the evaluation by a senior psychiatrist.
Background
Assessment of the capacity to consent to treatment is an
important legal and ethical issue in medicine. Providing
treatment against the wishes of a patient capable of con-
senting to treatment violates the principle of patient
autonomy and can often violate physician beneficence
[1]. Accurate assessment of the patient's capacity to con-
sent is therefore most important for decisions regarding
medical treatments which may have severe side effects or
even result in fatal outcomes [2]. The capacity to consent
to treatment requires the ability to understand and retain
information, to use this information as part of the deci-
sion-making process and to make free choices. This capac-
ity is specific to a particular decision and can be unstable.
In busy clinical practice, however, capacity to consent is
often presumed unless the patient refuses treatment [3] or
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der. This policy may be the best acceptable clinical and
ethical approach considering that it may be very difficult
to assess the capacity to consent in a situation where
patients have not yet been exposed to a specific choice
related to their health.
While capacity to consent to treatment depends on the
above-mentioned patient factors, the ability to realize this
capacity also depends on physician factors [4], such as
skills in explaining relevant medical facts adapted to the
patient's educational and cultural background. Several
studies have demonstrated difficulties associated with the
assessment of patients' capacity to consent to treatment
[5,6] by clinicians who tend to rely on informal clinical
impressions [7]. The aim of the present study was (i) to
identify the prevalence of patients lacking of capacity to
consent to treatment within the first 72 hours of admis-
sion to a general internal medicine ward of a university
hospital and (ii) to compare a standardized assessment by
means of the Silberfeld questionnaire with the assessment
by a multidisciplinary medical team or by a senior psychi-
atrist. Previous studies evaluating capacity to consent were
limited to homogeneous samples based on age [8],
pathology (psychiatric disorders [9-11], neurologic disor-
ders [12]), or medical setting (patients included in
research protocols or treated in the ambulatory care set-
tingn[13]).
Methods
The study was conducted in a general internal medical
ward at Lausanne University Hospital (CHUV) during a
three-month period from June 1 to August 31, 2007.
Assessment of the capacity to consent to treatment was
conducted during the first 72 hours following admission.
The research protocol was accepted by the hospital's ethics
committee and written consent was obtained from all par-
ticipating patients (and/or from their relatives and/or gen-
eral practitioner if capacity to consent was profoundly
altered).
Participants
Patients who refused to participate; who could not read or
speak French (and therefore were unable to fill in the Sil-
berfeld questionnaire) or who had major haemodynamic
instability were excluded. All other admitted patients were
included in the study. Patients with an obvious lack of
capacity to consent, such as unconscious patients or
patients who exhibited severe cognitive impairment, (i.e.
unable to communicate, to recall their date of birth or
their name) were considered without formal evaluation as
"incapable to consent to treatment" (as suggested by the
hospital's ethics committee, informed consent of these
patients was obtained from their general practitioner or
their relative).
Assessment
Capacity to consent is specific to a decision and can vary
over time; a patient is therefore competent or not with
respect to a specific decision and for a given moment in
time. The capacity to consent to the treatment or investi-
gation proposed during hospitalisation was evaluated
specifically for each patient according to the clinical situ-
ation. Each patient was assessed by a research fellow by
means of the Mini-Mental State Examination (MMSE)
and the Silberfeld questionnaire. The French version of
the MMSE was developed by the Working Group on Cog-
nitive Evaluations [14]; the original version was devel-
oped by Folstein et al (1975) as a method for grading
cognitive impairment (score between 0-30, with 0 indicat-
ing the most severe cognitive disturbances and a score
above 23/30 indicating no severe cognitive impairment)
[15]. The MMSE is a brief, easily administered test of sev-
eral cognitive functions which can play a significant role
in the process of decision-making and, therefore, to con-
sent. The test's validity and reliability have been demon-
strated in psychiatric, neurological, geriatric, and other
medical settings [16].
The Silberfeld questionnaire assesses adult patient's
capacity to consent to clinical treatment using two
vignettes describing common clinical situations [17].
Each vignette is read to a patient followed by nine ques-
tions concerning the vignette which leads to a score
between 0 and 10 points (lower scores indicating an
impaired capacity to consent). The same nine questions
are then applied to the actual medical situation of the
patient. Filling in the Silberfeld questionnaire takes about
30 to 45 minutes. The authors suggest that patients with a
score equal or superior to 6 are capable of consenting to
treatment.
The medical team, consisting of the resident or fellow, his
supervisor (a chief resident or a senior physician), the
nurse in charge of the patient and the referring general
practitioner were asked to indicate if the patient had or
had not (yes/no) the capacity to consent to investigations
or treatment.
The psychiatric assessment by a senior psychiatrist was
based on the guidelines described by Applebaum and
Grisso [18], which evaluate the patient's ability 1) to
appreciate the situation and its consequences, 2) to under-
stand the relevant information, 3) to manipulate the
information rationally and 4) to communicate and main-
tain a choice. The psychiatrist also looked for evidence of
psychopathology affecting capacity, such as delusions.
The first psychiatric evaluations were made in the pres-
ence of a psychiatrist who co-developed local guidelines
for the assessment of patient decision making capacity in
the general hospital [19].Page 2 of 8
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asked the medical team and the general practitioner about
their clinical impression and the psychiatrist who evalu-
ated the patients worked independently and did not have
access to the results of the different assessments.
Sociodemographic and medical information were
obtained from the medical charts of the participating
patients.
Statistical analysis
Correlation between Silberfeld and MMSE scores and
evaluations of the capacity to consent by members of the
medical team, referring general practitioner and the psy-
chiatrist were analysed using the SPSS version 9.0. To
identify overall agreement with the psychiatric assess-
ment, the receiver-operating curve (ROC) was calculated.
Data were analysed following the cut-off scores of the
MMSE and Silberfeld scores as recommended in the liter-
ature [17,20].
Results
Sample
The sample is described in figure 1.
Prevalence of incapacity to consent for treatment
Of the participating patients (n = 195), 26.7% (n = 52)
were considered as incapable to consent: 38 were uncon-
scious, unable to communicate or cognitively impaired to
a degree that they were unable to recall their name or date
of birth;14 qualified as incapable according to the psychi-
atric assessment.
Study sample
Sociodemographic and medical characteristics of evalu-
ated patients (n = 157) are listed in Table 1; their mean
age was 68.6 years old (SD 18.2), 59.2% (n = 93) were
women, 42.7% (N = 67) were married or lived with some-
one, 14% (n = 22) were single, 15.3% (n = 24) divorced
and 28% (n = 44) widowed. The principal reasons for hos-
pitalisation were pulmonary 29.3% (n = 46), cardiovascu-
lar 24.8% (n = 39) and digestive 21% (n = 33) disorders.
No association between sociodemographic variables and
capacity to consent was identified.
MMSE
With the MMSE cut-off score of 23, the prevalence of
patients with cognitive impairment was 15.3% (n = 24/
157). A MMSE score below 23 increased the probability of
incapacity based on the psychiatric assessment. However
16 patients were capable of consenting despite cognitive
impairment on the MMSE.
Silberfeld questionnaire
Agreement between the psychiatric assessment and the
Silberfeld questionnaire was poor (kappa 0.249), with a
sensitivity of 35.7% and a specificity of 91.6% (see Figure
2); using the Silberfeld score, 12 patients were classified
false positive and 9 false negative.
Opinions of the medical team
We considered the opinions of the medical team (resi-
dent, nurse and supervisor) individually and then the
majority decision of the medical team. The majority deci-
sion showed the highest agreement with the psychiatric
assessment (specificity and sensitivity of 94.3% and
78.6%, respectively); when compared to the psychiatric
assessment the opinion of the general practitioner
showed a specificity and sensitivity of 97.4% and 36.4%,
respectively. The sensitivity and specificity of the various
evaluations of capacity to consent to treatment are shown
in Table 2.
Disagreement among the medical team was observed for
22 patients (14% of the sample), with half of them (n =
11) considered as incapable of consenting to treatment by
the psychiatrist.
Discussion
The aim of this study was to identify the prevalence of
patients lacking capacity to consent to treatment within
the first 72 hours of admission to a general internal med-
icine ward of a university hospital. Of the patients (n = 52;
26.7%) who were identified to lack capacity to consent, a
majority (n = 38; 19.5%) exhibited obvious incapacity to
consent, (unconsciousness, severe cognitive impairment);
an additional 14 (7.2%) patients lacking capacity to con-
sent (almost a third of all patients lacking capacity to con-
sent) were identified by the psychiatrist. These findings
illustrate that besides the easily identifiable patients, some
patients have to be evaluated in order to determine their
incapacity to consent.
70 patients had to be excluded due to the impossibility of
evaluating them (haemodynamic instability, French not
spoken) or their refusal to participate to a study. This is a
limitation of the study since prevalence of patients unable
to consent may have been influenced by the excluded
patients; however it is not very probable that all of them,
especially the haemodynamically unstable, were compe-
tent. Patients who refused did so for various reasons
(fatigue, "no time", etc.) Their refusal was not explicitly
clarified and documented, since for ethical reasons their
refusal had to be respected. Although we did not know
how many of them refused due to incompetence, we do
not believe this was often the case.Page 3 of 8
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ardized assessment (the Silberfeld questionnaire, a tool
suggested by our institutional directive) with the assess-
ment by a multidisciplinary medical team or by a senior
psychiatrist. Our main finding was that the clinical team
is more accurate in assessing capacity to consent than
either an individual or a standardized test.
Confirming a previous study, no association was found
between demographic variables (age, education etc.) and
capacity to consent to treatment [21]. While capacity to
consent may possibly be the same across gender and edu-
cational variables, in elderly patients, cognitive deficits
may be more prevalent and thus influence the capacity to
consent. Our sample may not be large enough to detect
such differences.
Several studies have reported the inaccuracy of the stand-
ardized Mini Mental State Exam in determining capacity
to consent to treatment [7,22,23]. In line with these
results, we observed that the MMSE showed a specificity of
57.1% and a sensitivity of 88.8%. For example one patient
with an MMSE score of 29 was found to lack capacity to
The figure describes the recruitment flowchart with the number of patients potentially eligible, the number of patients excluded and the main reason for exclusionFigure 1
The figure describes the recruitment flowchart with the number of patients potentially eligible, the number of 
patients excluded and the main reason for exclusion. For the included patients the number (and the percentage) of 
patients considered to have (i) an evident incapacity to consent to treatment, (ii) an incapacity to consent to treatment based 
on the psychiatric assessment (iii) and a capacity to consent to treatment are listed.
-22 haemodynamic instability 
-20 French not spoken 
-28 other reasons :  refusal to participate, 
referral to another ward  or inability to 
complete all evaluations  
Evident incapacity to consent to 
treatment (unconsciousness, 
severe cognitive impairment)  
n=38 (19.5% ) 
195 patients included 
Exclusion (n =70) 
265 patients admitted in 3 
months 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Incapacity to consent to 
treatment by psychiatric 
assessment  
n=14 (7.2% ) 
Patients considered 
capable to consent to 
treatment 
n=143 (73,3% ) 
Patients fully assessed 
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for mental capacity to consent to treatment.
Age in years +/- Standard deviation 68.6 +/- 18.2
% N
Male gender 40.8 64
Highest level of education
Primary School 80.9 127
High school 10.2 16
College/University 8.9 14
Place of residence before admission
Independent home or flat 73.9 116
Health care at home 24.2 38
Nursing home 1.9 3
Marital Status
Married/in couple 42.7 67
single 14.0 22
Divorced 15.3 24
Widowed 28.0 44
Reason for hospitalization
cardiovascular disorder 24.8 39
pulmonary disorder 29.3 46
digestive disorder 21.0 33
Others disorders (renal, urogenital, metabolic, osteoarticular, neurologic, etc.) 24.9 39
Co-morbiditiesPage 5 of 8
(page number not for citation purposes)
BMC Medical Ethics 2009, 10:15 http://www.biomedcentral.com/1472-6939/10/15consent by the psychiatrist; this patient refused the inves-
tigation of a breast tumour because of delusional beliefs.
If a recommended Silberfeld score of 0-6 had been uti-
lized to identify incapacity to consent, 28% of the 195
included patients would have been classified as lacking
capacity to consent (a similar percentage to the prevalence
found by the psychiatrist); however, the specificity of the
Silberfeld score was poor. A previous study revealed that
clinical impressions (treating physician) were inaccurate
in determining capacity to consent to treatment [7]. For
this reason, we included a decision-support tool for the
assessment of the capacity to consent in this study. We are
aware that the Silberfeld does not represent the most accu-
rate instrument to evaluate competence We chose the Sil-
berfeld questionnaire because the institutional directive
of the hospital suggests it be used in daily clinical work
(other questionnaires supporting clinical judgement were
considered too time consuming. Although the Silberfeld
questionnaire offers guiding principles to assess capacity
to consent [24], our findings suggest that this tool is not
appropriate for the acute care setting. Since the aim of the
study was not to compare different questionnaires for the
assessment of capacity to consent, the question whether
other specific questionnaires designed to assist the clini-
cian would have produced better results remains unan-
swered.
The opinions of clinicians, especially senior physicians,
were more accurate than the Silberfeld questionnaire. This
result confirms a prior study reporting that experienced
physicians were more likely to make accurate assessments
of capacity to consent than younger physicians, but that
their assessments could still be improved [25]. In review-
ing the cases with disagreement between supervising phy-
sicians and the psychiatric assessment, we found that
fluctuation of patients' clinical status could partially
explain the differences: of the 11 participants who were
falsely classified as capable of consenting by the supervi-
sors, two showed a fluctuating clinical status (delirium,
acute confusional state). A decision shared by the differ-
ent clinical team members was the best predictor for
agreement with the psychiatrist. However, if disagreement
among the clinical team occurs (i.e. disagreement
between one of the residents, chief residents or nurses) a
psychiatric consultation may be useful, since half of these
patients (11/22) were found to be incapable of consent-
ing.
The fact that the general practitioner may not have seen
the patient for some time may explain the doctor's rela-
tively poor performance in assessing the patient's capacity
to consent. However, it is important to raise the con-
sciousness of general practitioners with regard to this
issue, since many of them were surprised and puzzled
when asked about their patient's capacity to consent to
treatment
The psychiatrist assessing patients' capacity to consent was
a senior staff member (SF). Another limitation of this
study may arise from the fact that all the results were com-
pared to a single psychiatrist's opinion. However, the
study psychiatrist has been specifically trained and based
her clinical judgment on a standardised guideline. She
was also supervised for the first evaluation by an experi-
enced liaison psychiatrist (FS) who participated in the
development of the local guidelines for the assessment of
capacity to consent.
Our study was limited to the French speaking patients;
indeed 7.5% of 265 patients were excluded due to lan-
guage barriers. The fact that the medical setting was not
cardiovascular 70.0 110
pulmonary 38.9 61
digestive 39.5 62
renal 38.2 60
metabolic 38.9 61
osteoarticular 30.6 48
urogenital 23.6 37
neurologic 19.1 30
psychiatric 15.9 25
Table 1: Personal and clinical characteristics of patients (n = 157) admitted to the general internal medicine wards who were assessed 
for mental capacity to consent to treatment. (Continued)Page 6 of 8
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(translation, cultural mediation), could increase the prev-
alence of patients lacking of ability to realise their capacity
to consent to treatment.
Conclusion
Given the high percentage of patients incapable of con-
senting to treatment and the observed difficulty of the
medical staff in determining the capacity to consent, there
is a clear need for reliable and valid assessment methods
of patients admitted to an acute medical ward. This study
demonstrated that a specific tool, such as the Silberfeld
questionnaire, is less useful than an interdisciplinary eval-
uation by clinicians. Other instruments, such as the
MacArthur Competence Assessment Tool-Treatment
(MacCAT-T) [26] will have to be evaluated and compared
to other methods for the assessment of capacity to consent
in future studies. The medico-legal contexts with regard to
capacity to consent may vary in different countries but the
capacity to consent remains an important ethical and legal
aspect of patient care in all settings. Our study demon-
strates that standardized tools, which can evaluate
patients' capacity to consent, and which have been proven
to be effective in identifying patients unable to consent
patients, are currently lacking. Since a clinical judgement
based on a shared interdisciplinary evaluation appears to
be the best available option to respect ethico-legal obliga-
tions to assess patient capacity, a sound understanding of
consent and its accurate evaluation in practice should
form part of pre and postgraduate training.
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